Peptide record

TPDB92086

NRC-03 Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity modified_plain modified
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92086
NRC-03
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab AFP-GFuse Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis
modified_plain
Yes
A 26-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
GRRKRKWLRRIGKGVKIIGGAALDHL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
26 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial Activity
skin mucous secretions of winter flounder Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 45 µg/ml
Anticancer
45 µg/mL

Target

Oral Cancer
CAL-27
Tongue

Assay & Model

CCK-8 assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 45 µg/ml
Anticancer
45 µg/mL

Target

Oral Cancer
SCC-9
Tongue

Assay & Model

CCK-8 assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022